Skip to main content

Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on May 22, 2025.

via HealthDay

THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States, according to a study published online May 20 in BMJ Open.

Yunhao Liu, from Gilead Sciences Inc. in Foster City, California, and colleagues conducted a matched case-control study involving patients with AD aged 50 years and older diagnosed between 2006 and 2021 identified from the IQVIA PharMetrics Plus claims database to examine the association between HSV-1 and AD. Controls were matched with individuals with AD on age, sex, region, database entry year, and health care visit numbers in a 1:1 ratio (344,628 AD case-control pairs).

The researchers found that 0.44 and 0.24 percent of patients with AD and controls, respectively, had a history of HSV-1 diagnosis. There was an association for HSV-1 diagnosis with an increased risk for AD (adjusted odds ratio, 1.80). Compared with those who did not use antiherpetics, patients with HSV-1 who used antiherpetics were less likely to develop AD (adjusted hazard ratio, 0.83).

"These findings place an even greater emphasis on viewing the prevention of herpesviruses as a public health priority," the authors write. "Further research to determine whether suppression of neurotropic viruses can alter the natural history of AD and AD-related dementia is warranted based on the consistent observational studies."

Several authors disclosed ties to the pharmaceutical industry, including Gilead Sciences, which funded the study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Greater Neighborhood Disadvantage Tied to Inflammatory, Alzheimer Disease Biomarkers

THURSDAY, July 3, 2025 -- Greater neighborhood disadvantage is associated with increased inflammatory and Alzheimer disease (AD) cerebrospinal fluid (CSF) biomarkers in older...

Lower Risk of Alzheimer Disease Seen for Breast Cancer Survivors

MONDAY, June 30, 2025 -- Breast cancer survivors have a lower risk of Alzheimer disease (AD) compared with cancer-free controls, according to a study published online June 20 in...

Late-Life Mood Disorders May Indicate Predisposition to Dementia

MONDAY, June 30, 2025 -- Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study published online June 9...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.